MRPS18CP4

Across TCGA pan-cancer cohorts, MRPS18CP4 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MRPS18CP4 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MRPS18CP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MRPS18CP4 expression acts as an unfavorable survival marker, although some lineages such as BLCA and SKCM show a favorable association.

STAD, BLCA, and KICH are the cancer types where MRPS18CP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.445	0.689	.001	57	view →
BLCA	DFS	Tertile	III,IV	0.630	0.412	.011	45	view →
KICH	OS	Tertile	II,III,IV	0.093	0.841	<.001	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
COAD	OS	Tertile	IV	0.123	0.681	.008	30	view →
ACC	OS	Tertile	All	0.674	0.885	.002	30	view →
LIHC	DFS	Tertile	II,III,IV	0.170	0.437	.009	24	view →
SKCM	OS	Tertile	III,IV	0.789	0.365	.016	18	view →
UCEC	DFS	Tertile	All	0.827	0.903	.009	18	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
PAAD	DFS	Tertile	All	0.499	0.260	.040	6	view →
CESC	DFS	Tertile	All	0.727	0.494	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MRPS18CP4–STAD (OS)

Open the STAD breakdown →